AGUZZI, Chiara

AGUZZI, Chiara  

Dip. MEDICINA ED ONCOLOGIA SPERIMENTALE (attivo dal 01/01/1900 al 30/04/2013)  

Mostra records
Risultati 1 - 6 di 6 (tempo di esecuzione: 0.011 secondi).
Titolo Data di pubblicazione Autore(i) File
How many patients can proceed from chronic myeloid leukaemia diagnosis to deep molecular response and long-lasting imatinib discontinuation? A real life experience 2017 Ferrero D.; Cerrano M.; Crisa E.; Aguzzi C.; Giai V.; Boccadoro M.
IMATINIB DISCOTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS ON 28 UNSELECTED PATIENTS 2014 Cerrano, M; Fava, C; Pregno, P; Giai, V; Nicolosi, M; Aguzzi, C; Dogliotti, I; Rege-Cambrin, G; Boccadoro, M; Vitolo, U; Saglio, G; Ferrero, D
Long-term therapy-free remission in a patient with platelet-derived growth factor receptor beta-rearranged myeloproliferative neoplasm. 2016 Cerrano, M; Crisà, E; Gottardi, E; Aguzzi, C; Boccadoro, M; Ferrero, D.
Prognostic value of JAK2V617F, CALR and MPL mutational status on outcome and thrombotic risk in a retrospective cohort of 138 patients with Essential THrombocythemia 2014 Benevolo, G.; Riera, L.; Nicolino, B.; Evangelista, A.; Beggiato, E.; Aguzzi, C.; Nicolosi, M.; Frairia, C.; Vitolo, U
Retrospective analysis of 260 patients with essential thrombocythemia: iwg-mrt (ipset model; passamonti et al, blood 2012) prognostic score is a good predictor of survival 2014 Benevolo, G.; Nicolino, B.; Beggiato, E.; Frairia, C.; Evangelista, A.; Pirillo, F.; Manzini, Pm.; Riera, L.; Aguzzi, C.; Vitolo, U
Treatment-free remission in chronic myeloid leukemia harboring atypical BCRABL1 transcripts 2020 Dragani M.; Petiti J.; Rege-Cambrin G.; Gottardi E.; Daraio F.; Caocci G.; Aguzzi C.; Crisa E.; Andreani G.; Caciolli F.; Fava C.